FDA sets review date for SpinalMotion's artificial disc

05/8/2013 | MassDevice.com (Boston)

An FDA panel will meet on July 24 to evaluate SpinalMotion's premarket approval application for the Kineflex/C system. The metal-on-metal total disc replacement device, which is already available in Europe, is intended for one-level repair of the intervertebral disc in patients who have undergone single-level discectomy for lumbar degenerative disc disease.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY